A landmark appeals court ruling clears way for Purdue Pharma-Sackler bankruptcy deal

In a landmark ruling Tuesday, a federal appeals court in New York cleared the way for a bankruptcy deal for opioid manufacturer Purdue Pharma.

The deal will shield members of the Sackler family, who own the company, from future lawsuits.

The 2nd Circuit Court of Appeals spent more than a year reviewing the case after a lower court ruled it was improper for Purdue Pharma's bankruptcy deal to block future lawsuits against the Sackler family.

The Sacklers earned billions of dollars from the sale of OxyContin and other opioids.